Blue Laser Triggered Hemostatic Peptide Hydrogel for Gastrointestinal Bleeding Treatment
Advanced Materials · 2024
DOI: 10.1002/adma.202405290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Qiang Luo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xinqiao Hospital, No. 183, Xinqiao Street, Chongqing, 400037, China. Hauptthemen laut MEDLINE: Hydrogels, Gastrointestinal Hemorrhage, Peptides, Hemostatics. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In an emergency, nonvariceal upper gastrointestinal bleeding (NVUGIB), endoscopic hemostasis is considered the gold standard intervention. However, current endoscopic hemostasis is very challenging to manage bleeding in large‐diameter or deep lesions highly prone to rebleeding risk. Herein, a novel hemostatic peptide hydrogel (HPH) is reported, consisting of a self‐assembly peptide sequence CFLIVIGSIIVPGDGVPGDG (PFV) and gelatin methacryloyl (GelMA), which can be triggered by blue laser endoscopy (BLE) for nonvariceal upper gastrointestinal bleeding treatment without recurring bleeding concerns. Upon contact with GelMA solution, PFV immediately fibrillates into β‐sheet nanofiber and solvent‐induced self‐assembly to form HPH gel. HPH nanofiber networks induced ultrafast coagulation by enveloping blood cells and activating platelets and coagulation factors even to the blood with coagulopathy. Besides its remarkable hemostatic performance in artery and liver injury models, HPH achieves instant bleeding management in porcine NVUGIB models within 60 s by preventing the rebleeding risk. This work demonstrates an extraordinary hemostatic agent for NVUGIB intervention by BLE for the first time, broadening potential application scenarios, including patients with coagulopathy and promising clinical prospects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Xinqiao Hospital, No. 183, Xinqiao Street, Chongqing, 400037, China.
- Department of Mechanical Engineering, University of Manitoba, Winnipeg, R3T 2N2, Manitoba, Canada.
- Clinical Medical Research Center, Xinqiao Hospital, No.183, Xinqiao Street, Chongqing, 400037, China.
- Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, N6A 5B9, Canada.
- Chongqing Municipality Clinical Research Center for Gastroenterology, Chongqing, 400037, China.
ORCID-Profile: Kibret Mequanint, Malcolm Xing
Zitieren
APA
Luo, Q., Luo, J., Luan, Z., Xu, K., Tian, L., Zhang, K., Peng, X., Yuan, M., Zheng, C., Shu, Z., Zhang, Y., Tan, S., Dan, R., Mequanint, K., Fan, C., Xing, M., & Yang, S. (2024). Blue Laser Triggered Hemostatic Peptide Hydrogel for Gastrointestinal Bleeding Treatment. Advanced Materials. https://doi.org/10.1002/adma.202405290
Vancouver
Luo Q, Luo J, Luan Z, Xu K, Tian L, Zhang K, et al. Blue Laser Triggered Hemostatic Peptide Hydrogel for Gastrointestinal Bleeding Treatment. Advanced Materials. 2024. doi:10.1002/adma.202405290
BibTeX
@article{Luo2024,
author = {Luo, Qiang and Luo, Jie and Luan, Zhaohui and Xu, Kaige and Tian, Lixing and Zhang, Kebin and Peng, Xue and Yuan, Mengxue and Zheng, Chuanhao and Shu, Zhenzhen and Zhang, Yuchen and Tan, Shali and Dan, Ruijue and Mequanint, Kibret and Fan, Chaoqiang and Xing, Malcolm and Yang, Shiming},
title = {Blue Laser Triggered Hemostatic Peptide Hydrogel for Gastrointestinal Bleeding Treatment},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202405290}
}
EUVIMED